VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,879,000 | +34.1% | 336,000 | +126.7% | 0.34% | +29.6% |
| Q3 2016 | $3,638,000 | +163.4% | 148,200 | +182.3% | 0.26% | +202.3% |
| Q1 2016 | $1,381,000 | -90.6% | 52,500 | -36.3% | 0.09% | -76.6% |
| Q3 2015 | $14,700,000 | -15.0% | 82,409 | +5.9% | 0.37% | 0.0% |
| Q2 2015 | $17,290,000 | +148.7% | 77,831 | +122.4% | 0.37% | +85.9% |
| Q1 2015 | $6,952,000 | +56.7% | 35,000 | +12.9% | 0.20% | +48.9% |
| Q4 2014 | $4,436,000 | -52.5% | 31,000 | -56.4% | 0.13% | -46.4% |
| Q3 2014 | $9,335,000 | +83.8% | 71,153 | +76.7% | 0.25% | +65.3% |
| Q2 2014 | $5,079,000 | +25.4% | 40,268 | +31.0% | 0.15% | +10.3% |
| Q1 2014 | $4,051,000 | – | 30,731 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |